MedPath

青岛华仁太医药业有限公司

Ownership
-
Established
2005-10-31
Employees
-
Market Cap
-
Website
hrtaiyi.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

NMPA:14

Drug Approvals

蒲元和胃胶囊

Approval Number
国药准字Z20090720
Approval Date
Sep 4, 2023
NMPA

Oyster Shell Calcium Capsules

Product Name
牡蛎碳酸钙胶囊
Approval Number
国药准字H20173250
Approval Date
Jun 22, 2022
NMPA

益母草颗粒

Approval Number
国药准字Z20173029
Approval Date
Feb 12, 2022
NMPA

Oyster Shell Calcium Granules

Product Name
牡蛎碳酸钙颗粒
Approval Number
国药准字H20173025
Approval Date
Nov 19, 2021
NMPA

复生康片

Approval Number
国药准字Z20153059
Approval Date
Jul 30, 2020
NMPA

Polystictus Glycopeptide Capsules

Product Name
云芝胞内糖肽胶囊
Approval Number
国药准字H32026181
Approval Date
May 30, 2020
NMPA

炎宁片

Approval Number
国药准字Z20153016
Approval Date
Feb 7, 2020
NMPA

心脑欣片

Approval Number
国药准字Z20153015
Approval Date
Feb 3, 2020
NMPA

复方苦木消炎胶囊

Approval Number
国药准字Z20153012
Approval Date
Feb 3, 2020
NMPA

复方苦木消炎胶囊

Approval Number
国药准字Z20153013
Approval Date
Feb 3, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.